Correlation between circulating mutant DNA and metabolic tumour burden in advanced non-small cell lung cancer patients

BACKGROUND: Mutated circulating cell-free DNA (cfDNA) has been suggested as a surrogate marker of tumour burden and aggressiveness of disease. We examined the association between the level of plasma mutant cfDNA and metabolic tumour burden (MTB) measured by (18)F-fluoro-D-glucose positron emission t...

Descripción completa

Detalles Bibliográficos
Autores principales: Winther-Larsen, Anne, Demuth, Christina, Fledelius, Joan, Madsen, Anne Tranberg, Hjorthaug, Karin, Meldgaard, Peter, Sorensen, Boe Sandahl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572172/
https://www.ncbi.nlm.nih.gov/pubmed/28683468
http://dx.doi.org/10.1038/bjc.2017.215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572172/
https://www.ncbi.nlm.nih.gov/pubmed/28683468
http://dx.doi.org/10.1038/bjc.2017.215

Ejemplares similares